Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
40
IRTC Quote, Financials, Valuation and Earnings
Last price:
$179.38
Seasonality move
:
11.18%
Day range:
$178.99 - $190.00
52-week range:
$86.99 - $212.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.11x
P/B ratio:
47.43x
Volume:
1.1M
Avg. volume:
392.8K
1-year change:
92.94%
Market cap:
$5.8B
Revenue:
$591.8M
EPS (TTM):
-$1.62
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
$199.8M | $0.06 | 21.66% | -80.89% | $220.27 |
|
ATEC
Alphatec Holdings, Inc.
|
$209.2M | $0.04 | 18.33% | -91.85% | $24.92 |
|
ATRC
AtriCure, Inc.
|
$139.3M | -$0.05 | 12.08% | -83.91% | $52.33 |
|
BAX
Baxter International, Inc.
|
$2.8B | $0.54 | 2.57% | 118.69% | $23.27 |
|
IART
Integra LifeSciences Holdings Corp.
|
$429.6M | $0.80 | -2.94% | 217.65% | $15.50 |
|
TNDM
Tandem Diabetes Care, Inc.
|
$276.9M | -$0.09 | -2.02% | -4.07% | $24.81 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
$179.43 | $220.27 | $5.8B | -- | $0.00 | 0% | 8.11x |
|
ATEC
Alphatec Holdings, Inc.
|
$22.65 | $24.92 | $3.4B | -- | $0.00 | 0% | 4.61x |
|
ATRC
AtriCure, Inc.
|
$41.46 | $52.33 | $2.1B | -- | $0.00 | 0% | 3.80x |
|
BAX
Baxter International, Inc.
|
$21.07 | $23.27 | $10.8B | 167.20x | $0.01 | 2.47% | 0.98x |
|
IART
Integra LifeSciences Holdings Corp.
|
$13.58 | $15.50 | $1.1B | 70.14x | $0.00 | 0% | 0.63x |
|
TNDM
Tandem Diabetes Care, Inc.
|
$22.50 | $24.81 | $1.5B | -- | $0.00 | 0% | 1.49x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
85.74% | 2.412 | 13.23% | 4.47x |
|
ATEC
Alphatec Holdings, Inc.
|
94.39% | 1.682 | 27.26% | 1.21x |
|
ATRC
AtriCure, Inc.
|
14.82% | 1.966 | 4.73% | 2.72x |
|
BAX
Baxter International, Inc.
|
57.29% | -0.374 | 83.18% | 0.96x |
|
IART
Integra LifeSciences Holdings Corp.
|
65.91% | 0.037 | 179.84% | 1.47x |
|
TNDM
Tandem Diabetes Care, Inc.
|
77.16% | 1.942 | 54.61% | 1.79x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IRTC
iRhythm Technologies, Inc.
|
$137.1M | -$4M | -6.2% | -54.18% | -2.08% | $20.1M |
|
ATEC
Alphatec Holdings, Inc.
|
$118.1M | -$9.4M | -25.96% | -1495.13% | -4.79% | $3.1M |
|
ATRC
AtriCure, Inc.
|
$100.6M | $208K | -5.3% | -6.2% | 0.16% | $24.1M |
|
BAX
Baxter International, Inc.
|
$938M | $194M | -1.9% | -4.83% | 6.84% | $126M |
|
IART
Integra LifeSciences Holdings Corp.
|
$226.1M | $25.9M | -14.85% | -37.15% | 6.43% | $25.8M |
|
TNDM
Tandem Diabetes Care, Inc.
|
$134.3M | -$20.1M | -31.16% | -110.24% | -8.05% | $4.2M |
iRhythm Technologies, Inc. vs. Competitors
-
Which has Higher Returns IRTC or ATEC?
Alphatec Holdings, Inc. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -14.54%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Alphatec Holdings, Inc.'s return on equity of -1495.13%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M ATECAlphatec Holdings, Inc.60.12% -$0.19 $626.3M -
What do Analysts Say About IRTC or ATEC?
iRhythm Technologies, Inc. has a consensus price target of $220.27, signalling upside risk potential of 22.76%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.92 which suggests that it could grow by 10.04%. Given that iRhythm Technologies, Inc. has higher upside potential than Alphatec Holdings, Inc., analysts believe iRhythm Technologies, Inc. is more attractive than Alphatec Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.12 1 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is IRTC or ATEC More Risky?
iRhythm Technologies, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.311%.
-
Which is a Better Dividend Stock IRTC or ATEC?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or ATEC?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $196.5M. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than Alphatec Holdings, Inc.'s net income of -$28.6M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.11x versus 4.61x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.11x -- $192.9M -$5.2M ATECAlphatec Holdings, Inc.4.61x -- $196.5M -$28.6M
-
Which has Higher Returns IRTC or ATRC?
AtriCure, Inc. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -0.2%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat AtriCure, Inc.'s return on equity of -6.2%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M ATRCAtriCure, Inc.74.9% -$0.01 $559.4M -
What do Analysts Say About IRTC or ATRC?
iRhythm Technologies, Inc. has a consensus price target of $220.27, signalling upside risk potential of 22.76%. On the other hand AtriCure, Inc. has an analysts' consensus of $52.33 which suggests that it could grow by 26.23%. Given that AtriCure, Inc. has higher upside potential than iRhythm Technologies, Inc., analysts believe AtriCure, Inc. is more attractive than iRhythm Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.12 1 0 ATRCAtriCure, Inc.5 0 0 -
Is IRTC or ATRC More Risky?
iRhythm Technologies, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison AtriCure, Inc. has a beta of 1.401, suggesting its more volatile than the S&P 500 by 40.078%.
-
Which is a Better Dividend Stock IRTC or ATRC?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AtriCure, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. AtriCure, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or ATRC?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are larger than AtriCure, Inc. quarterly revenues of $134.3M. iRhythm Technologies, Inc.'s net income of -$5.2M is lower than AtriCure, Inc.'s net income of -$267K. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while AtriCure, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.11x versus 3.80x for AtriCure, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.11x -- $192.9M -$5.2M ATRCAtriCure, Inc.3.80x -- $134.3M -$267K
-
Which has Higher Returns IRTC or BAX?
Baxter International, Inc. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -1.8%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Baxter International, Inc.'s return on equity of -4.83%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M BAXBaxter International, Inc.33.09% $0.02 $16.9B -
What do Analysts Say About IRTC or BAX?
iRhythm Technologies, Inc. has a consensus price target of $220.27, signalling upside risk potential of 22.76%. On the other hand Baxter International, Inc. has an analysts' consensus of $23.27 which suggests that it could grow by 10.43%. Given that iRhythm Technologies, Inc. has higher upside potential than Baxter International, Inc., analysts believe iRhythm Technologies, Inc. is more attractive than Baxter International, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.12 1 0 BAXBaxter International, Inc.2 13 1 -
Is IRTC or BAX More Risky?
iRhythm Technologies, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison Baxter International, Inc. has a beta of 0.594, suggesting its less volatile than the S&P 500 by 40.626%.
-
Which is a Better Dividend Stock IRTC or BAX?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Baxter International, Inc. offers a yield of 2.47% to investors and pays a quarterly dividend of $0.01 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Baxter International, Inc. pays out 180.98% of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or BAX?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Baxter International, Inc. quarterly revenues of $2.8B. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than Baxter International, Inc.'s net income of -$51M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Baxter International, Inc.'s PE ratio is 167.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.11x versus 0.98x for Baxter International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.11x -- $192.9M -$5.2M BAXBaxter International, Inc.0.98x 167.20x $2.8B -$51M
-
Which has Higher Returns IRTC or IART?
Integra LifeSciences Holdings Corp. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -1.34%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Integra LifeSciences Holdings Corp.'s return on equity of -37.15%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M IARTIntegra LifeSciences Holdings Corp.56.24% -$0.07 $3B -
What do Analysts Say About IRTC or IART?
iRhythm Technologies, Inc. has a consensus price target of $220.27, signalling upside risk potential of 22.76%. On the other hand Integra LifeSciences Holdings Corp. has an analysts' consensus of $15.50 which suggests that it could grow by 14.14%. Given that iRhythm Technologies, Inc. has higher upside potential than Integra LifeSciences Holdings Corp., analysts believe iRhythm Technologies, Inc. is more attractive than Integra LifeSciences Holdings Corp..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.12 1 0 IARTIntegra LifeSciences Holdings Corp.2 4 2 -
Is IRTC or IART More Risky?
iRhythm Technologies, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison Integra LifeSciences Holdings Corp. has a beta of 1.025, suggesting its more volatile than the S&P 500 by 2.536%.
-
Which is a Better Dividend Stock IRTC or IART?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra LifeSciences Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Integra LifeSciences Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or IART?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Integra LifeSciences Holdings Corp. quarterly revenues of $402.1M. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than Integra LifeSciences Holdings Corp.'s net income of -$5.4M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Integra LifeSciences Holdings Corp.'s PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.11x versus 0.63x for Integra LifeSciences Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.11x -- $192.9M -$5.2M IARTIntegra LifeSciences Holdings Corp.0.63x 70.14x $402.1M -$5.4M
-
Which has Higher Returns IRTC or TNDM?
Tandem Diabetes Care, Inc. has a net margin of -2.7% compared to iRhythm Technologies, Inc.'s net margin of -8.49%. iRhythm Technologies, Inc.'s return on equity of -54.18% beat Tandem Diabetes Care, Inc.'s return on equity of -110.24%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Technologies, Inc.71.09% -$0.16 $854.9M TNDMTandem Diabetes Care, Inc.53.88% -$0.31 $582.2M -
What do Analysts Say About IRTC or TNDM?
iRhythm Technologies, Inc. has a consensus price target of $220.27, signalling upside risk potential of 22.76%. On the other hand Tandem Diabetes Care, Inc. has an analysts' consensus of $24.81 which suggests that it could grow by 10.27%. Given that iRhythm Technologies, Inc. has higher upside potential than Tandem Diabetes Care, Inc., analysts believe iRhythm Technologies, Inc. is more attractive than Tandem Diabetes Care, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Technologies, Inc.12 1 0 TNDMTandem Diabetes Care, Inc.7 13 0 -
Is IRTC or TNDM More Risky?
iRhythm Technologies, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison Tandem Diabetes Care, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.218%.
-
Which is a Better Dividend Stock IRTC or TNDM?
iRhythm Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tandem Diabetes Care, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Technologies, Inc. pays -- of its earnings as a dividend. Tandem Diabetes Care, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or TNDM?
iRhythm Technologies, Inc. quarterly revenues are $192.9M, which are smaller than Tandem Diabetes Care, Inc. quarterly revenues of $249.3M. iRhythm Technologies, Inc.'s net income of -$5.2M is higher than Tandem Diabetes Care, Inc.'s net income of -$21.2M. Notably, iRhythm Technologies, Inc.'s price-to-earnings ratio is -- while Tandem Diabetes Care, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Technologies, Inc. is 8.11x versus 1.49x for Tandem Diabetes Care, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Technologies, Inc.8.11x -- $192.9M -$5.2M TNDMTandem Diabetes Care, Inc.1.49x -- $249.3M -$21.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
